The changes in ERK1/2 activities appear to be a key mechanism for the regulation of depression by paeoniflorin, as ERK1/2 inhibition can abolish the antidepressant effect of paeoniflorin (Zhong et al., 2019). This evidence concerns the gene MAPK3 and depressive disorder.